Loading Events

« All Events

  • This event has passed.

Access to Innovation

February 23 @ 8:00 am - 8:00 pm

Our 8th Annual Access to Innovation conference was a full day event that brought together life sciences leaders from academia, research, health institutions, government, and industry to discuss emerging trends, innovation, economic impact, translational science, and policies to advance the sector. This year’s event resumed in person.

The BC life sciences sector has never been stronger, leading the country in the pace of discovery and company creation. By leveraging our world-class research, we are well-positioned to deliver innovative product solutions and services critical to the health system while driving economic diversification and competitiveness.

As leaders, we need to seize the opportunity to significantly advance the sector and ensure that BC builds on the extraordinary momentum of the last few years by working together to develop policies and strategies that attract capital and talent and enable scale. The time for sustained collaborative action – between industry, research and academia, and government – is now.

Confirmed Speakers:

  • Ali Ardakani, Founder & Managing Director, Novateur Ventures; Board Chair, Life Sciences BC
  • Paul Armitage, Partner, Gowling WLG
  • Dr. Julia Bickford, Regional Director, Research Evaluation and Analytics, Northern Health
  • Linda Buchanan, Chair, Invest Vancouver Management Board; Mayor, City of North Vancouver
  • Dr. Michael Chen, Clinical Pathologist, Department of Laboratory Medicine, Island Health; Adjunct Assistant Professor, University of British Columbia & University of Victoria
  • Lisa Chu, Dean, School of Health Sciences, British Columbia Institute of Technology
  • Abi Coman-Walker, COO, Acuitas Therapeutics
  • Stephen Filby, Founder & Principal Consultant, WestPAR Consultancy
  • Dr. Christine Genge, Associate Director, Global Talent Acquisition, STEMCELL Technologies
  • Dr. David Goodlett, Professor, University of Victoria; Director, University of Victoria-Genome BC Proteomics Centre
  • Dr. Fraser Hof, AVP Research, University of Victoria
  • Dr. Diana Ionescu, Clinical Professor, University of British Columbia; Consultant Pathologist, BC Cancer Agency
  • Dr. Tim Jacobs, Director, Molecular Design & Engineering, AbCellera
  • Dr. Shirin Kalyan, VP, Scientific Innovation, Qu Biologics
  • Dr. Barb Kinnaird, CEO, Response Biomedical
  • Dr. Darryl Knight, VP Research & Academic Affairs, Providence Health Care
  • Dr. Véronique Lecault, COO, AbCellera
  • Dr. Elicia Maine, Professor, Innovation & Entrepreneurship, and Associate VP, Knowledge Mobilization & Innovation, Simon Fraser University
  • Jennifer Marles, Partner, Oyen Wiggs
  • Dr. Murray McCutcheon, Senior VP Partnering, AbCellera
  • Dr. Robert McMaster, Vice Dean, Research & Professor, Department of Medical Genetics, University of British Columbia
  • Nathan Michaels, Director, Precision Medicine and Genetic Services, Ministry of Health
  • Alison Orth, Director, Clinical Trials BC, Michael Smith Health Research BC
  • Dr. Federica Di Palma, CSO & VP, Research and Innovation, Genome BC
  • Eric Petersson, Trade Commissioner, Pacific Regional Office, Global Affairs Canada
  • Darcia Pope, Chief Transformation Officer & Vice President, Innovation & Planetary Health, Vancouver Coastal Health
  • Andrea Sambati, President and CEO, Boehringer Ingelheim Canada
  • Angie Schick, Executive Director, New Ventures BC
  • Helen Sheridan, Chief Human Resources Officer, STEMCELL Technologies
  • Raymond Shih, Director, Data Products & Services, LifeLabs
  • Dr. Cynthia Shippam, Industry Technology Advisor, National Research Council Canada – IRAP
  • Dr. Ted Steiner, Professor, Medicine & Head of the Division of Infectious Diseases, University of British Columbia
  • Dr. Gavin C.E. Stuart, Professor, Department Obstetrics and Gynecology, University of British Columbia
  • Dr. James Taylor, Co-Founder, General Manager, Precision NanoSystems
  • Dr. Ali Tehrani, Venture Partner, Amplitude Ventures
  • Dr. Bryan Tennant, Scientific Director, Medical Affairs – Vaccines, GSK
  • Carlene Todd, VP Access, Roche
  • Laura Walsh, Senior Vice President, Philanthropy, VGH & UBC Hospital Foundation
  • Dr. Stephen Yip, Neuropathologist, Vancouver General Hospital; Medical Director of CGL/CCG, BC Cancer

With remarks from the Honourable Brenda Bailey, Minister of Jobs, Economic Development and Innovation, Government of British Columbia

Confirmed Session Themes:

  • Emerging Trends in the Talent Supply Chain
  • Evolving Access to Innovations in Precision Medicine
  • Increasing Access to Innovations for Patients Who Need Them: Moving Forward in Partnership
  • Engineering Next-Generation Immune Responses and Translation to Biomanufacturing
  • Innovations in Infection and Immunity
  • Less is More, the Future of mRNA Therapeutics Manufacturing
  • Leveraging Vaccine Research to Reimagine the Future
  • Licensing and Collaboration Agreements in the Life Sciences Sector
  • Navigating Government Support of IP Strategies
  • Remarks from LifeLabs
  • Unleashing the Potential of Clinical Trials in BC: A Vision Takes Shape

Date: February 23, 2022

Location: Vancouver Convention Centre West – Level 3


Guest Arrival: 8:00am PT

Programming: 8:30am-6:30pm PT

Networking Reception: 6:30pm-8:00pm PT

Buffet lunch and light reception refreshments will be provided.

For more information, please contact:

Claire Nelson

Manager, Events


Office: (604) 669-9909 Ext. 105


February 23
8:00 am - 8:00 pm
Event Category:

Newsletter Signup